Found 4 articles for: "Ustekinumab"
Differential RNA Transcriptome in Ustekinumab Responders vs Non-Responders
February 2023 | Volume 22 | Issue 2 | Features | 219 | Copyright © February 2023
Despite numerous available psoriasis treatments, no "one size fits all" regimen provides complete disease control without side effects, logistical obstacles, and/or expense. Despite increasingly effic...
Read MoreSuccessful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab
March 2022 | Volume 21 | Issue 3 | Case Reports | 317 | Copyright © March 2022
Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and...
Read MoreUstekinumab in the Management of Hidradenitis Suppurativa: A Retrospective Study
March 2022 | Volume 21 | Issue 3 | Editorials | 319 | Copyright © March 2022
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by the formation of recurrent abscesses in apocrine-bearing areas. In advanced stages, chronic inflammation leads to...
Read MoreEarly Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab
February 2022 | Volume 21 | Issue 2 | Original Article | 122 | Copyright © February 2022
Background: The identification of early treatment factors that predict the long-term success of maintenance therapy for psoriasis may help optimize individual therapy.
O...
Read More
